Cargando…

A Competing Risk Analysis Model to Determine the Prognostic Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast Cancer Patients Based on the Surveillance, Epidemiology, and End Results Database

INTRODUCTION: Knowledge of the association between isolated tumor cells (ITCs) in breast cancer patients and the outcome is very limited. We aimed to determine the prognostic value of axillary lymph node ITCs for T1N0M0 female breast cancer (FBC) patients. METHODS: Data for T1N0M0 FBC patients stage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yijun, Zhang, Huimin, Zhang, Wei, Ren, Yu, Qiao, Yan, Li, Kunlong, Chen, Heyan, Pu, Shengyu, He, Jianjun, Zhou, Can
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531361/ https://www.ncbi.nlm.nih.gov/pubmed/33072606 http://dx.doi.org/10.3389/fonc.2020.572316

Ejemplares similares

Nomogram Predicts the Role of Contralateral Prophylactic Mastectomy in Male Patients With Unilateral Breast Cancer Based on SEER Database: A Competing Risk Analysis
por: Li, Kunlong, et al.
Publicado: (2021)

The prognostic significance of further axillary dissection for sentinel lymph node micrometastases in female breast cancer: A competing risk analysis using the SEER database
por: Zhou, Yudong, et al.
Publicado: (2022)

Research on the Role of Combined Chemotherapy and Radiotherapy in Patients With N+ Non-Metastatic Metaplastic Breast Carcinoma: A Competing Risk Analysis Model Based on the SEER database, 2000 to 2015
por: Ma, Yifei, et al.
Publicado: (2021)

A Novel Risk-Scoring System to Identify the Potential Population Benefiting From Adjuvant Chemotherapy for Node-Negative TNBC Patients With Tumor Size Less Than 1 cm
por: Li, Yijun, et al.
Publicado: (2022)

Research on Effectiveness of Prior Cancer on Survival Outcomes for Patients with Nonmetastatic Triple-Negative Breast Cancer: A Competing Risk Analysis and Propensity Score Matching Analysis of the SEER Database
por: Chen, Heyan, et al.
Publicado: (2021)

Risk factors for axillary lymph node metastases in clinical stage T1-2N0M0 breast cancer patients
por: Zhang, Yuanxin, et al.
Publicado: (2019)

Evaluation of outcome of chemotherapy for breast cancer patients older than 70 years: A SEER-based study
por: Pu, Shengyu, et al.
Publicado: (2023)

A risk stratification model to predict chemotherapy benefit in medullary carcinoma of the breast: a population-based SEER database
por: Chen, Heyan, et al.
Publicado: (2023)

Nomogram models for stratified prediction of axillary lymph node metastasis in breast cancer patients (cN0)
por: Gao, Xin, et al.
Publicado: (2022)

A negative binomial regression model for risk estimation of 0–2 axillary lymph node metastases in breast cancer patients
por: Zeng, De, et al.
Publicado: (2020)

Breast Axillary Lymph Node Metastasis
por: Cavalli, Luciane R., et al.
Publicado: (2011)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Axillary surgery in the case of limited involved axillary lymph nodes
por: Kolberg, Hans-Christian, et al.
Publicado: (2023)

A nomogram to identify appropriate candidates for breast-conserving surgery among young women with breast cancer: A large cohort study
por: Pu, Shengyu, et al.
Publicado: (2022)

Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases
por: Zheng, Jianwei, et al.
Publicado: (2018)

Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas
por: Das, Sushant Kumar, et al.
Publicado: (2021)

The Role of Axillary Lymph Node Dissection in Tubular Carcinoma of the Breast: A Population Database Study
por: Chen, Shuang-Long, et al.
Publicado: (2019)

Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022)

Value of Breast MRI and Nomogram After Negative Axillary Ultrasound for Predicting Axillary Lymph Node Metastasis in Patients With Clinically T1-2 N0 Breast Cancer
por: Song, Sung Eun, et al.
Publicado: (2023)

Rare metastasis of gastric cancer to the axillary lymph node: A case report
por: Zhu, Qingshun, et al.
Publicado: (2022)

Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection
por: Li, Baiyu, et al.
Publicado: (2023)

Prognostic Nomogram Based on the Metastatic Lymph Node Ratio for T(1-4)N(0-1)M(0) Pancreatic Neuroendocrine Tumors After Surgery
por: Shi, Jingxiang, et al.
Publicado: (2022)

Ectopic Schistosomiasis Involving Axillary Lymph Nodes
por: Chen, Xia, et al.
Publicado: (2022)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer
por: Kim, Ji-Yoon, et al.
Publicado: (2011)

Evaluation of the Property of Axillary Lymph Nodes and Analysis of Lymph Node Metastasis Factors in Breast Cancer by Ultrasound Elastography
por: Zhou, Jia, et al.
Publicado: (2022)

Outcomes of Sentinel Lymph Node Dissection Alone vs. Axillary Lymph Node Dissection in Early Stage Invasive Lobular Carcinoma: A Retrospective Study of the Surveillance, Epidemiology and End Results (SEER) Database
por: Wang, Jun, et al.
Publicado: (2014)

Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Comparison of indocyanine green and methylene blue use for axillary reverse mapping during axillary lymph node dissection
por: Wu, Jun‐Dong, et al.
Publicado: (2020)

Papillary Thyroid Carcinoma With Axillary Lymph Node Metastasis
por: Khan, Mehvish, et al.
Publicado: (2021)

Axillary lymph node dissection: Dead or still alive?
por: Beck, Anna C., et al.
Publicado: (2023)

The nodal positivity rate in breast pCR patients with initially, clinically node-negative breast cancer after neoadjuvant systemic therapy: A systematic review and meta-analysis
por: Ma, Le, et al.
Publicado: (2023)

Effect of the Nipple-Excising Breast-Conserving Therapy in Female Breast Cancer: A Competing Risk Analysis and Propensity Score Matching Analysis of Results Based on the SEER Database
por: Li, Shouyu, et al.
Publicado: (2022)

200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up
por: Reitsamer, R, et al.
Publicado: (2004)

Effectiveness of Quantitative Shear Wave Elastography for the Prediction of Axillary Lymph Node Metastasis
por: Cheng, Yingying, et al.
Publicado: (2022)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

Inconsistent radiotherapy effects between primary tumors and axillary lymph nodes
por: Bi, Zhao, et al.
Publicado: (2022)

The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012)
por: Li, Yijun, et al.
Publicado: (2023)

Virtual lymph node analysis to evaluate axillary lymph node coverage provided by tangential breast irradiation
por: Park, Shin-Hyung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_794jn55f2bb8pgbopepj7ruldi